Disease modifying effects of N-butyryl glucosamine in a streptococcal cell wall induced arthritis model in rats

Journal of Rheumatology

Volumn 34, Issue 4, 2007, Pages 712-720

  Wang, Susanne X ^a,b   Cherian, Annie ^a,b   Dumitriu, Mircea ^a,b   Grynpas, Marc D ^a,b   Carran, John ^c   Wainman, Dan ^c   Anastassiades, Tassos ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Arthritis; N butyryl glucosamine; Rats; Streptococcal

Indexed keywords

GLUCOSAMINE DERIVATIVE; N BUTYRYLGLUCOSAMINE; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BACTERIAL CELL WALL; BONE DEFECT; BONE DENSITY; BONE PLATE; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EPIPHYSIS; FEMALE; FEMUR; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STREPTOCOCCUS; THREE DIMENSIONAL IMAGING; TIBIA;

EID: 34247398373     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bogoch ER, Moran E. Abnormal bone remodelling in inflammatory arthritis. Can J Surg 1998;41:264-71.
2. Duncan H. Cellular mechanisms of bone damage and repair in the arthritic joint. J Rheumatol Suppl 1983;11:29-37.
3. Sokoloff L. Osteoarthritis as a remodeling process. J Rheumatol 1987;14 Spec No:7-10.
4. Goldring SR. Bone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol 2002;29 Suppl 65:44-8.
5. Anastassiades T, Rees-Milton K. Biochemical markers for osteoarthritis: from the present to the future and back to the past [editorial], J Rheumatol 2005;32:578-9.
6. Tchetina EV, Squires G, Poole AR, Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 2005;32:876-86.
7. Hooyman JR, Melton LJ III, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 1984;27:1353-61.
8. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993;306:558.
9. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T, Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91.
10. McGonagle D, Conaghan PG, O'Connor P, et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999;42:1706-11.
11. Klarlund M, Ostergaard M, Rostrup E, Skjodt H, Lorenzen I. Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls. Scand J Rheumatol 2000;29:108-15.
12. Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology Oxford 2003;42 Suppl 2:ii11-ii16.
13. Wyllie JC. Histopathology of the subchondral bone lesion in rheumatoid arthritis. J Rheumatol Suppl 1983;11:26-8.
14. Scott DL, Pugner K, Kaarela K, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology Oxford 2000;39:122-32.
15. Pincus T. Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 1988;41:1037-41.
16. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL, The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
17. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706-20.
18. Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, Countryman PJ. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998;41:1583-90.
19. Chan E, Pandith V, Towheed TE, Brouillard D, Zee B, Anastassiades TP. Comparison of the combined cortical thickness of the second metacarpal with Sharp's method for scoring hand microradiographs in rheumatoid arthritis. J Rheumatol 1998;25:1290-4.
20. Yu W, Xie YZ, Jiang M, et al. CT detection of wrist bone erosion in rheumatoid arthritis. Chin Med J Engl 1993;106:509-13.
21. Choy EH, Smith C, Dore CJ, Scott DL. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology Oxford 2005;44:1414-21.
22. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001;1:CD002946.
23. Cibere J, Kopec JA, Thome A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 2004;51:738-45.
24. Development of N-acylated glucosamines (GlcNAcyls) for arthritic conditions. 5th ICRS Symposium, Ghent, Belgium: 2004.
25. Terry DE, Rees-Milton K, Smith P, et al. N-acylation of glucosamine modulates chondrocyte growth, proteoglycan synthesis, and gene expression. J Rheumatol 2005;32:1775-86.
26. Poustie MW, Carran J, McEleney K, Dixon SJ, Anastassiades TP, Bernier SM. N-butyryl glucosamine increases matrix gene expression by chondrocytes. J Pharmacol Exp Ther 2004;311:610-6.
27. Brockhausen I, Carran J, McEleney K, et al. N-Acyl derivatives of glucosamine as acceptor substrates for galactosyltransferase from bone and cartilage cells.Carbohydr Res 2005;340:1997-2003.
28. Aghazadeh-Habashi A, Carran J, Anastassiades T, Jamali F. High performance liquid chromatographic determination of N-butyryl glucosamine in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2005;819:91-6.
29. Tiraloche G, Girard C, Chouinard L, et al. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum 2005;52:1118-28.
30. Xxxxx. CRC Handbook of Animal Models for the Rheumatic Diseases. Ref Type: Serial (Book,Monograph). CRC Press Inc., 1988.
31. Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta. J Exp Med 1993;177:225-30.
32. Kimpel D, Dayton T, Fuseler J, et al, Splenectomy attenuates streptococcal cell wall-induced arthritis and alters leukocyte activation. Arthritis Rheum 2003;48:3557-67.
33. Nagy TR, Prince CW, Li J. Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. J Bone Miner Res 2001;16:1682-7.
34. Feldkamp LA, Goldstein SA, Parfitt AM, Jesion G, Kleerekoper M. The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 1989;4:3-11.
35. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999;14:1167-74.
36. Parisien M, Mellish RW, Silverberg SJ, et al. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 1992;7:913-9.
37. Chan JM, Villarreal G, Jin WW, Stepan T, Burstein H, Wahl SM. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 2002;6:727-36.
38. Funk JL, Chen J, Downey KJ, Davee SM, Stafford G. Blockade of parathyroid hormone-related protein prevents joint destruction and granuloma formation in streptococcal cell wall-induced arthritis. Arthritis Rheum 2003;48:1721-31.
39. Barrie HJ. Pathology of femoral heads in patients with rheumatoid disease. J Rheumatol 1990;17:448-59.
40. Eulderink F, Meijers KA. Pathology of the cervical spine in rheumatoid arthritis: a controlled study of 44 spines. J Pathol 1976;120:91-108.
41. Bruser P. Pathology of the sesamoid bones of the hand [German]. Handchir Mikrochir Plast Chir 1994;26:302-6.
42. Badger AM, Griswold DE, Kapadia R, et al. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 2000;43:175-83.
43. Wahl SM, Allen JB, Hines KL, et al. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 1994;94:655-62.
44. Rees-Milton KJ, Terry D, Anastassiades TP. Hyperglycosylation of fibronectin by TGF-beta 1-stimulated chondrocytes. Biochem Biophys Res Commun 2004;317:844-50.
45. Nesher G, Moore TL, Grisanti MW, el Najdawi E, Osborn TG. Correlation of antiperinuclear factor with antibodies to streptococcal cell-wall peptidoglycan-polysaccharide polymers and rheumatoid factor. Clin Exp Rheumatol 1991;9:611-5.